Beckman Laser Institute Medical clinic
Irvine, California, 92612, United States
NCT Number: NCT00786539
The objective of this research protocol is to continue investigation of the nature and prevalence of mitochondria disease and to aid patients and health care providers in the understanding of these complex disorders.
This research study brings together many clinical sub-specialists to address the etiology of these disorders and to develop more effective approaches for their diagnoses and more reliable prognoses.
Looking for future studies?
Notify Me1 day and older
All sexes
Observational
Irvine, California, 92612, United States
The non-invasive device named Diffuse Optical Spectroscopy developed at the Beckman Laser Institute is to be used to measure various physiological parameters. Since mitochondria produce most of the energy necessary for cellular function, their efficacy is most important for systems with a high energy demand like the brain, heart, skeletal muscle, kidney, liver, and endocrine tissues. As a result, mitochondria diseases usually manifest as complex, multi-organ disorders, requiring multispecialty investigations.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
mitochondria
Time frame: Up to 12 weeks
University of California, Irvine
Other
Investigation of the Nature and Prevalence of Mitochondria Disease
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02154711
Metabolic Diseases, Mitochondrial Disease
Philadelphia, Pennsylvania, United States
View Trial DetailsNCT04643249
Metabolic Diseases, Mitochondrial Disease
Leeds, United Kingdom
View Trial DetailsNCT02544217
Brain Diseases, Brain Diseases, Metabolic
Ghent, Belgium
View Trial DetailsNCT02985710
Brain Diseases, Brain Diseases, Metabolic
Boston, Massachusetts, United States
View Trial Details